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Su-Hua Wu, MD, PHD, Xiao-Xiong Lin, MD, Yun-Jiu Cheng, MD, Can-Can Qiang, MD,
Jing Zhang, MD
Guangzhou, China
Objectives A meta-analysis was performed to determine the risk and incidence rate of arrhythmia death, cardiac death, and
all-cause death in the general population with the early repolarization pattern (ERP).
Background The ERP has recently been associated with vulnerability to ventricular fibrillation in case-control studies. How-
ever, the prognostic significance of the ERP in the general population is controversial.
Methods Relevant studies published through July 31, 2012, were searched and identified in the MEDLINE and Embase
databases. Studies that reported risk ratio estimates with 95% confidence intervals (CIs) for the associations of
interest were included. Data were extracted, and summary estimates of association were obtained using a
random-effects model.
Results Of the 9 studies included, 3 studies reported on arrhythmia death (31,981 subjects, 1,108 incident cases during
726,741 person-years of follow-up), 6 studies reported on cardiac death (126,583 subjects, 10,010 incident
cases during 2,054,674 person-years of follow-up), and 6 studies reported on all-cause death (112,443 subjects,
22,165 incident cases during 2,089,535 person-years of follow-up). The risk ratios of the ERP were 1.70 (95%
CI: 1.19 to 2.42; p  0.003) for arrhythmia death, 0.78 (95% CI: 0.27 to 2.25; p  0.63) for cardiac death, and
1.06 (95% CI: 0.87 to 1.28; p  0.57) for all-cause death. The estimated absolute risk differences of subjects
with the ERP were 70 cases of arrhythmia death per 100,000 subjects per year. J-point elevation  0.1 mV in
the inferior leads and notching configuration had an increased risk for arrhythmia death in subgroup studies.
Conclusions The ERP was associated with increased risk and a low to intermediate absolute incidence rate of arrhythmia
death. Further study is needed to clarify which subgroups of subjects with the ERP are at higher risk for arrhyth-
mia death. (J Am Coll Cardiol 2013;61:645–50) © 2013 by the American College of Cardiology Foundation
Published by Elsevier Inc. http://dx.doi.org/10.1016/j.jacc.2012.11.023The early repolarization pattern (ERP), which is character-
ized by an elevation  0.1 mV of the QRS-ST junction (J
point) in the inferior and/or lateral leads on 12-lead elec-
trocardiography, has recently been associated with vulnera-
bility to ventricular fibrillation in case-control studies (1–4).
However, the prognostic significance of the ERP in the
general population is controversial. Some studies have found
no significant association between the ERP and cardiac
mortality (5–7), whereas other studies recently showed that
the ERP was associated with increased risk for arrhythmia
death, cardiac death, or all-cause death (7–12).
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2012, accepted November 8, 2012.At the same time, most studies of the ERP have reported
only the association between the ERP and risk for death
from arrhythmia or cardiac causes, although with routine
follow-up, little is known about the incidence of arrhythmia
death or cardiac death in the general population with the
ERP.
Therefore, we conducted a meta-analysis to summarize
all published prospective studies and case-control studies to
date on the risk and incidence of cardiac death, arrhythmia
death, and all-cause death in the general population with
the ERP.
Methods
The meta-analysis was conducted according to the checklist
of the Meta-Analysis of Observational Studies in Epidemi-
ology group (13). We performed a systematic search
of relevant studies published through July 31, 2012, in the
MEDLINE and Embase databases.
Search strategy. Accessing MEDLINE and Embase, we
performed a search for studies published through July 31, 2012,
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and key words: “early repolariza-
tion” and “J-wave.” We manually
checked the reference list of each
report. In addition, we reviewed
the reference lists of retrieved re-
ports to identify any studies that
were not identified from the pre-
liminary searches.
Study selection. Studies were included in the meta-
analysis if they met the following criteria: published in the
English language, used a prospective design or case-control
design, and presented estimates of risk ratios (RRs) or
hazard ratios with 95% confidence intervals (CIs) or re-
ported data necessary to calculate these. Seven prospective
observational cohort studies and 3 case-control studies have
been conducted in which the association between the ERP
and risk for cardiac death, arrhythmia death, or all-cause
death was assessed.
Data extraction. From each retrieved report, we extracted
the following data: name of the lead investigator, year of
publication, country where the study was performed, pri-
mary and secondary end points, follow-up time, methods
for assessment of end points, proportions of men and
women, total number of subjects, person-years of follow-up,
number of events, confounding factors that were adjusted
for in the analysis, and RRs or hazard ratios with 95% CIs.
We extracted multivariate-adjusted estimates with and
without adjustment for the variables of sex, age, body mass
index, left ventricular hypertrophy, diabetes mellitus, coro-
nary artery disease, and smoking status.
Statistical analysis. RRs and 95% CIs were calculated or
recalculated for each study and pooled in both fixed-effects
and random-effects models. Heterogeneity among studies
was formally assessed using Q and I2 statistics. Publication
ias was tested using Egger’s regression test. We calculated
bsolute risk differences (RDs) on the basis of the obtained
ummary estimate and incidence rates of subjects without
he ERP during follow-up. We performed the analysis
sing Stata version 11 (StataCorp LP, College Station,
exas), RevMan 5 (Cochrane Collaboration, Oxford,
nited Kingdom), and SPSS version 13 (SPSS, Inc.,
hicago, Illinois). Two-sided p values 0.05 were consid-
red statistically significant.
esults
he results of the search are shown in Figure 1. We
etrieved 1,408 reports in our preliminary search. Of these,
0 were identified for full review (some reported analyses on
1 relevant outcome). Three studies reported the associa-
ion between the ERP and the risk for arrhythmia death, 6
tudies reported the association between the ERP and the
isk for cardiac death, 6 studies reported the association
etween the ERP and the risk for all-cause death, and 3
Abbreviations
and Acronyms
CI  confidence interval
ERP  early repolarization
pattern
RD  risk difference
RR  risk ratioase-control studies reported the association between theRP and the risk for arrhythmia death. After full review, 1
tudy of arrhythmia death was excluded because it defined
he ERP as an elevation  0.05 mV of the QRS-ST
unction (J point) in the inferior and/or lateral leads on
2-lead electrocardiography. Of the 10 studies, 9 were
ncluded in the meta-analysis.
tudy characteristics. The characteristics of the included
tudies are shown in Table 1. For risk for arrhythmia death
3 studies), the total number of subjects was 31,981, with
,108 events during 726,741 person-years of follow-up. For
isk for cardiac death (6 studies), the total number of
ubjects was 126,583, with 10,010 events during 2,054,674
erson-years of follow-up. For risk for all-cause death
6 studies), the total number of subjects was 112,443, with
2,165 deaths during 2,089,535 person-years of follow-up.
he mean follow-up durations were 24 years for arrhythmia
eath, 18 years for cardiac death, and 20 years for all-cause
eath. The number of potential confounding factors in-
luded in the multivariate-adjusted model varied.
In 2 case-control studies, the ERP was more commonly
bserved among patients with idiopathic ventricular fibrillation
han among matched control subjects (31.1% vs. 5.9%, p 
.001). Compared with subjects without the ERP, case sub-
ects with the ERP were at increased risk for recurrent
entricular fibrillation (RR: 2.1; 95% CI: 1.2 to 3.5).
isk for death. Table 2 shows the results of the random-
ffects meta-analysis of the relationships between the ERP
nd arrhythmia, cardiac, and all-cause death. The ERP was
ssociated with a higher risk for death from arrhythmia
RR: 1.70; 95% CI: 1.19 to 2.42; p 0.003) but not cardiac
auses (RR: 0.78; 95% CI: 0.27 to 2.25; p  0.640) or all
auses (RR: 1.06; 95% CI: 0.87 to 1.28; p  0.570). In the
ubgroup studies, J-point elevation  0.2 mV and  0.1
Figure 1 Selection of Studies Included in the Meta-Analysis
ECG  electrocardiography.
a
p
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February 12, 2013:645–50 Early Repolarization and Arrhythmia DeathmV in the inferior leads had a higher risk for death from
arrhythmia (RR: 3.02; 95% CI: 1.84 to 4.96; p 0.001; and
RR: 1.58; 95% CI: 1.27 to 1.96; p  0.001, respectively)
nd from cardiac causes (RR: 2.98; 95% CI: 1.85 to 4.94;
 0.001; and RR: 1.48; 95% CI: 1.27 to 1.73; p  0.001,
respectively). Notching configuration had an increased risk
for death from arrhythmia (RR: 1.48; 95% CI: 1.06 to 2.08;
p  0.022). There was no evidence of publication bias (p 
0.22) in the subject risk estimates for arrhythmia death.
Incidence rate of death. Events per 1,000 person-years of
arrhythmia, cardiac, and all-cause death were 1.68, 4.81,
and 17.06 in subjects with the ERP during follow-up,
respectively. The ERP was associated with a higher risk for
arrhythmia mortality (RR: 1.70; 95% CI: 1.19 to 2.42; p 
0.003) (Fig. 2, Table 3) but not cardiac mortality (RR: 0.78;
95% CI: 0.27 to 2.21; p  0.63) or all-cause mortality (RR:
1.06; 95% CI: 0.85 to 1.31; p 0.62) (Fig. 2, Table 3). The
absolute RD of arrhythmia death was 0.07% (p  0.005)
(Fig. 3). The corresponding absolute RD on the basis of
Characteristics of the Included StudiesTable 1 Characteristics of the Included Studies
First Author (Year) (Ref. #) Location
Men
(%)
Mean Age
(yrs)
Follow-Up
(yrs)
Cohort studies
Sinner et al. (2010) (9) Germany 48.9 52 10 18.9
Tikkanen et al. (2009) (8) Finland 52.4 44 8 30 11
Haruta et al. (2011) (7) Japan 43.7 47 15 24 15
Olson et al. (2011) (11) United States 44.3 54 17 4
Uberoi et al. (2011) (6) United States 87 55 15 7.6 3.8
Klatsky et al. (2003) (5) United States 44 42.5 14
Rollin et al. (2012) (12) France 1.6 49.8 8.6 14.2 2.0
Case-control studies
Haissaguerre et al. (2008) (1) Multinational 63.6 36 12 5.1 4.2
Rosso et al. (2008) (4) United States 71 38 3
ERP  early repolarization pattern; NA  not available; VF  ventricular fibrillation.
Risk for Death From Arrhythmia, Cardiac Causes, and All Causes inTable 2 Risk for Death From Arrhythmia, Cardiac Causes, and
All-Cause Death
Events
(Subjects) RR (95% CI)* p Value
ERP
All ERP positive 1,899 (5,566) 1.06 (0.87–1.28) 0.57 3
All ERP negative 20,503 (106,877) 9,5
J-point elevation
0.1 mV in inferior leads 393 (858) 1.42 (0.75–2.71) 0.285 1
0.2 mV in inferior leads 18 (36) 1.54 (1.06–2.24) 0.03
0.1 mV in lateral leads 169 (262) 1.19 (1.02–1.39) 0.04
0.1 mV in both inferior
and lateral leads
10 (16) 1.30 (0.70–2.43) 0.42
Configuration
Notching NA NA NA
Slurring NA NA NA*Adjusted for sex, age, body mass index, left ventricular hypertrophy, diabetes mellitus, coronary artery d
CI  confidence interval; ERP  early repolarization pattern; NA  not available; RR  risk ratio.subjects without the ERP was estimated to be 70 cases of
arrhythmia death per 100,000 subjects per year for subjects
with the ERP.
Sensitivity analysis. The summary estimates were consis-
tent when analyses were repeated using a fixed-effects
model. Omitting 1 study at a time and recalculating the
pooled RRs for the remainder of the studies showed that
none of the individual studies substantially influenced the
pooled RR for any of the outcomes.
Discussion
The ERP has been considered to be a benign finding in the
asymptomatic, healthy population (14–17). However, the
prognostic significance of the ERP in general population
has recently become controversial (5–12,18–26).
The results of this meta-analysis of prospective studies
suggest that the ERP is consistently associated with higher
risk for arrhythmia death but not cardiac death or all-cause
io of
(%)
Number
of Events
Total Number of Subjects/
Person-Years End Point
3.1 2,251 6,213/323,076 Cardiac death, all-cause death
5.8 8,897 10,864/325,920 Cardiac death, all-cause death,
arrhythmia death
3.9 3,515 5,976/143,424 All-cause death, cardiac death,
arrhythmia death
2.3 3,555 15,141/257,397 Arrhythmia death, all-cause
death,
3.2 1,995 29,281/222,536 Cardiac death
0.9 11,075 73,088/102,3232 All-cause death, cardiac death
3.2 77 157/16,254 All-cause death, cardiac death
1.0 796 206/1,047 Recurrent VF
1.1 45 169/NA NA
jects With ERPauses in Subjects With ERP
Cardiac Death Arrhythmia Death
ts
cts) RR (95% CI)* p Value
Events
(Subjects) RR (95% CI)* p Value
364) 0.78 (0.27–2.25) 0.64 142 (3,925) 1.70 (1.19–2.42) 0.003
2,219) 966 (28,056)
043) 1.48 (1.27–1.73) 0.001 97 (1,161) 1.58 (1.27–1.96) 0.001
) 2.98 (1.85–4.92) 0.001 16 (72) 3.02 (1.84–4.96) 0.001
1) 1.12 (0.72–1.77) 0.618 38 (1,092) 0.88 (0.60–1.27) 0.484
9) 1.22 (0.54–2.73) 0.632 13 (462) 2.14 (1.01–4.54) 0.047
2) 0.60 (0.30–1.30) 0.200 38 (1,028) 1.48 (1.06–2.08) 0.022
9) 0.90 (0.50–1.50) 0.600 31 (438) 1.23 (0.86–1.78) 0.263Rat
ERP
1
2
1
1
3
3SubAll C
Even
(Subje
87 (4,
70 (12
64 (1,
17 (36
76 (74
8 (17
6 (29
13 (31isease, and smoking status.
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Early Repolarization and Arrhythmia Death February 12, 2013:645–50death. We observed RRs of 1.70 for arrhythmia death, 0.78
for cardiac death, and 1.06 for all-cause death in subjects
with the ERP. On the basis of incidence rates in subjects
without the ERP, we estimated that the absolute RD was 70
cases per 100,000 subjects per year for arrhythmia death. In
subgroup studies, J-point elevation 0.1 mV in the inferior
leads (RR: 1.58) and notching configuration (RR: 1.48)
Figure 2 Incidence Rates and RRs of Arrhythmia, Cardiac, and
The early repolarization pattern (ERP) was associated with a higher risk for arrhyth
0.003) but not cardiac mortality (RR: 0.78; 95% CI: 0.27 to 2.21; p  0.63) or al
arrhythmia, cardiac, and all-cause deaths during follow-up. “Total” represents pers
Incidence Rates and Risks for Arrhythmia Deathand All-Cause De th in Subjects With ERP DurinTable 3 Incide ce Rates and Risks for Arrhyand All-Cause Death in Subjects Wi
Events per
ERP Positive
Primary end point
All-cause death 1,899/111,331
Cardiac death 387/80,388
Arrhythmia death 142/84,346
Subgroup study: J-point elevation
0.1 mV in inferior leads 90/22,170
0.2 mV in inferior leads 16/2,196
0.1 mV in lateral leads 31/16,106
Configuration
Notching 38/25,852
Slurring 31/12,483CI  confidence interval; ERP  early repolarization pattern; RR  risk ratio.were associated with a higher risk for arrhythmia death in
subjects with the ERP.
How the ERP increases the risk for arrhythmia death
remains unclear. The current experimental studies support
that J-point elevation is a marker of increased transmural
heterogeneity of ventricular repolarization, which increases
the vulnerability to ventricular fibrillation (27–30).
ause Death in Subjects With the ERP During Follow-Up
ortality (risk ratio [RR]: 1.70; 95% confidence interval [CI]: 1.19 to 2.42; p 
mortality (RR: 1.06; 95% CI: 0.85 to 1.31; p  0.62). “Events” represents
rs during follow-up. M-H  Mantel-Haenszel.
diac Death,llow-Upa Death, Cardiac Death,
P During Follow-Up
n-Years
ERP Negative RR (95% CI) p Value
,503/1,771,583 1.06 (0.85–1.31) 0.62
,570/1,747,749 0.78 (0.27–2.21) 0.63
966/640,004 1.70 (1.19–2.42) 0.003
— 1.72 (1.39–2.13) 0.00001
— 3.06 (1.87–4.99) 0.00001
— 0.8 (0.56–1.14) 0.22
— 1.54 (1.11–2.15) 0.01
— 1.36 (0.95–1.94) 0.09All-C
mia m
l-cause
on-yea, Carg Fothmi
th ER
Perso
20
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February 12, 2013:645–50 Early Repolarization and Arrhythmia DeathAlthough we identified a higher risk for arrhythmia
death, the data from this meta-analysis also reveal a low to
intermediate absolute incidence rate of arrhythmia death
(70 cases per 100,000 person-years of follow-up) in subjects
with the ERP. Therefore, future clinical and experimental
studies should focus on understanding the exact mecha-
nisms and reasons for the ERP and clarifying which
subgroups of subjects with ERP are at higher risk for
arrhythmia death.
Study limitations. There were some limitations to this
meta-analysis. First, the relatively small number of studies
limited our ability to identify which subgroups were at
higher risk for reported events. Second, the small number of
studies also limited our ability to determine whether heter-
ogeneity in summary estimates was explained by factors
related to study quality. Third, we cannot exclude the
possibility of subject confounding and bias due to misclas-
sification. Although the included studies attempted to
control various known risk factors, the possibility of subject
or unmeasured confounding cannot be ruled out.
Strengths of this study include large sample sizes, long
durations of follow-up, and well-established prospective
studies or case-control studies. In addition, our pooled
estimates were based on prospective analyses with detailed
adjustment for confounding variables.
Conclusions
The findings of our meta-analysis of prospective studies
suggest the ERP is associated with increased risk and a low
to intermediate absolute incidence rate of arrhythmia death.
Future clinical and experimental studies should focus on
understanding the exact mechanisms and reasons for the
ERP and clarifying which subgroups of subjects with the
ERP are at higher risk for arrhythmia death.
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